Kevin Kearney
About Kevin Kearney
Kevin Kearney is a Regional Sales Manager at Ceribell, Inc, with over 18 years of experience in commercial medical device leadership. He has held various management roles at companies such as Cardinal Health and Welch Allyn, and he holds an MBA from Saint Louis University.
Work at Ceribell
Kevin Kearney has been serving as the Regional Sales Manager at Ceribell, Inc since 2019. In this role, he is responsible for overseeing sales operations and driving growth within the organization. His extensive background in the medical device industry supports his efforts in promoting innovative solutions. Ceribell focuses on advancing healthcare technology, and Kearney's leadership contributes to the company's objectives in the market.
Previous Experience in Medical Device Sales
Before joining Ceribell, Kearney held several positions at Cardinal Health and Welch Allyn. He worked at Cardinal Health as a Region Manager for Hospital Supply from 2010 to 2013 and as a Presource Sales Consultant from 2007 to 2010. At Welch Allyn, he served as a Strategic Account Manager from 2013 to 2016 and as Area Vice President from 2013 to 2019. His roles involved managing sales teams and developing strategic market initiatives.
Education and Expertise
Kevin Kearney holds a Master of Business Administration (MBA) from Saint Louis University, which he obtained from 2015 to 2017. He also studied at the University of Wisconsin-Madison, where he earned a Bachelor of Arts degree. Additionally, he attended the University of Limerick, focusing on Psychology and Marketing. His educational background complements his over 18 years of experience in commercial medical device leadership.
Achievements in Sales Leadership
Kearney has a proven track record in sales leadership within the medical device sector. He has built and led national sales teams that successfully commercialized disruptive technologies, particularly in the operating room and ophthalmology markets. His experience includes serving as the Vice President of Sales for a tele-health solution targeting diabetic retinopathy, showcasing his ability to drive innovation in healthcare.